Oncology Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Oncology Drugs Market to 2027 - Global Analysis and Forecasts By Drug Class Type ( Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy ); Indication ( Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others )

Report Code: TIPRE00003421 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
In the recent years, the increased developments in pharmaceutical industry continue to make cancer more treatable. The rising prevalence of cancer led to rise in demand for cancer drugs worldwide. The oncology drugs are used in the diagnosis of cancer depends upon the stages of the progression. Different types of cancer such as, endocrine cancer, blood cancer, lung cancer, skin cancer, bone cancer, genitourinary cancer, breast cancer, gastrointestinal cancer, head & neck cancer, eye cancer and gynaecologic cancer can be treated by oncology drugs.

MARKET DYNAMICS
The oncology drugs market is anticipated to grow in the forecast period owing to driving factors such as, increasing demand for oncology medications worldwide, growing research activities in cancer diagnosis and rising demand for personalized medicines. Moreover, the worldwide growing geriatric population is anticipated to offer more growth opportunities for the players operating in the oncology drugs market.

MARKET SCOPE
The "Global Oncology Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of oncology drugs market with detailed market segmentation by drug class type, indication and geography. The global oncology drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oncology drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global oncology drugs market is segmented on the basis of drug class type and indication. Based on drug class type, the market is segmented as, chemotherapy, targeted therapy, immunotherapy (biologic therapy) and hormonal therapy. On the basis of indication, the global oncology drugs market is segmented as, lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer and others.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oncology drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oncology drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting oncology drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oncology drugs market in these regions.


MARKET PLAYERS

The reports cover key developments in the oncology drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from oncology drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for oncology drugs market in the global market. Below mentioned is the list of few companies engaged in the oncology drugs market.

The report also includes the profiles of key oncology drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Pfizer Inc.
• Merck & Co., Inc.
• JOHNSON & JOHNSON (Janssen Global Services, LLC)
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Bristol-Myers Squibb Company
• AstraZeneca
• AbbVie Inc.
• Astellas Pharma Inc.
• CELGENE CORPORATION

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oncology Drugs Market - By Drug Class Type
1.3.2 Oncology Drugs Market - By Indication
1.3.3 Oncology Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. ONCOLOGY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ONCOLOGY DRUGS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ONCOLOGY DRUGS MARKET - GLOBAL MARKET ANALYSIS

6.1. ONCOLOGY DRUGS - GLOBAL MARKET OVERVIEW
6.2. ONCOLOGY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ONCOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS TYPE

7.1. OVERVIEW
7.2. DRUG CLASS TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. TARGETED THERAPY
7.4.1. Overview
7.4.2. Targeted Therapy Market Forecast and Analysis
7.5. IMMUNOTHERAPY (BIOLOGIC THERAPY)
7.5.1. Overview
7.5.2. Immunotherapy (Biologic Therapy) Market Forecast and Analysis
7.6. HORMONAL THERAPY
7.6.1. Overview
7.6.2. Hormonal Therapy Market Forecast and Analysis

8. ONCOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION

8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER
8.3.1. Overview
8.3.2. Lung Cancer Market Forecast and Analysis
8.4. STOMACH CANCER
8.4.1. Overview
8.4.2. Stomach Cancer Market Forecast and Analysis
8.5. COLORECTAL CANCER
8.5.1. Overview
8.5.2. Colorectal Cancer Market Forecast and Analysis
8.6. BREAST CANCER
8.6.1. Overview
8.6.2. Breast Cancer Market Forecast and Analysis
8.7. PROSTATE CANCER
8.7.1. Overview
8.7.2. Prostate Cancer Market Forecast and Analysis
8.8. LIVER CANCER
8.8.1. Overview
8.8.2. Liver Cancer Market Forecast and Analysis
8.9. ESOPHAGUS CANCER
8.9.1. Overview
8.9.2. Esophagus Cancer Market Forecast and Analysis
8.10. CERVICAL CANCER
8.10.1. Overview
8.10.2. Cervical Cancer Market Forecast and Analysis
8.11. KIDNEY CANCER
8.11.1. Overview
8.11.2. Kidney Cancer Market Forecast and Analysis
8.12. BLADDER CANCER
8.12.1. Overview
8.12.2. Bladder Cancer Market Forecast and Analysis
8.13. OTHERS
8.13.1. Overview
8.13.2. Others Market Forecast and Analysis

9. ONCOLOGY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Oncology Drugs Market Overview
9.1.2 North America Oncology Drugs Market Forecasts and Analysis
9.1.3 North America Oncology Drugs Market Forecasts and Analysis - By Drug Class Type
9.1.4 North America Oncology Drugs Market Forecasts and Analysis - By Indication
9.1.5 North America Oncology Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Oncology Drugs Market
9.1.5.1.1 United States Oncology Drugs Market by Drug Class Type
9.1.5.1.2 United States Oncology Drugs Market by Indication
9.1.5.2 Canada Oncology Drugs Market
9.1.5.2.1 Canada Oncology Drugs Market by Drug Class Type
9.1.5.2.2 Canada Oncology Drugs Market by Indication
9.1.5.3 Mexico Oncology Drugs Market
9.1.5.3.1 Mexico Oncology Drugs Market by Drug Class Type
9.1.5.3.2 Mexico Oncology Drugs Market by Indication
9.2. EUROPE
9.2.1 Europe Oncology Drugs Market Overview
9.2.2 Europe Oncology Drugs Market Forecasts and Analysis
9.2.3 Europe Oncology Drugs Market Forecasts and Analysis - By Drug Class Type
9.2.4 Europe Oncology Drugs Market Forecasts and Analysis - By Indication
9.2.5 Europe Oncology Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Oncology Drugs Market
9.2.5.1.1 Germany Oncology Drugs Market by Drug Class Type
9.2.5.1.2 Germany Oncology Drugs Market by Indication
9.2.5.2 France Oncology Drugs Market
9.2.5.2.1 France Oncology Drugs Market by Drug Class Type
9.2.5.2.2 France Oncology Drugs Market by Indication
9.2.5.3 Italy Oncology Drugs Market
9.2.5.3.1 Italy Oncology Drugs Market by Drug Class Type
9.2.5.3.2 Italy Oncology Drugs Market by Indication
9.2.5.4 Spain Oncology Drugs Market
9.2.5.4.1 Spain Oncology Drugs Market by Drug Class Type
9.2.5.4.2 Spain Oncology Drugs Market by Indication
9.2.5.5 United Kingdom Oncology Drugs Market
9.2.5.5.1 United Kingdom Oncology Drugs Market by Drug Class Type
9.2.5.5.2 United Kingdom Oncology Drugs Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Oncology Drugs Market Overview
9.3.2 Asia-Pacific Oncology Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Oncology Drugs Market Forecasts and Analysis - By Drug Class Type
9.3.4 Asia-Pacific Oncology Drugs Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Oncology Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Oncology Drugs Market
9.3.5.1.1 Australia Oncology Drugs Market by Drug Class Type
9.3.5.1.2 Australia Oncology Drugs Market by Indication
9.3.5.2 China Oncology Drugs Market
9.3.5.2.1 China Oncology Drugs Market by Drug Class Type
9.3.5.2.2 China Oncology Drugs Market by Indication
9.3.5.3 India Oncology Drugs Market
9.3.5.3.1 India Oncology Drugs Market by Drug Class Type
9.3.5.3.2 India Oncology Drugs Market by Indication
9.3.5.4 Japan Oncology Drugs Market
9.3.5.4.1 Japan Oncology Drugs Market by Drug Class Type
9.3.5.4.2 Japan Oncology Drugs Market by Indication
9.3.5.5 South Korea Oncology Drugs Market
9.3.5.5.1 South Korea Oncology Drugs Market by Drug Class Type
9.3.5.5.2 South Korea Oncology Drugs Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Oncology Drugs Market Overview
9.4.2 Middle East and Africa Oncology Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Oncology Drugs Market Forecasts and Analysis - By Drug Class Type
9.4.4 Middle East and Africa Oncology Drugs Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Oncology Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Oncology Drugs Market
9.4.5.1.1 South Africa Oncology Drugs Market by Drug Class Type
9.4.5.1.2 South Africa Oncology Drugs Market by Indication
9.4.5.2 Saudi Arabia Oncology Drugs Market
9.4.5.2.1 Saudi Arabia Oncology Drugs Market by Drug Class Type
9.4.5.2.2 Saudi Arabia Oncology Drugs Market by Indication
9.4.5.3 U.A.E Oncology Drugs Market
9.4.5.3.1 U.A.E Oncology Drugs Market by Drug Class Type
9.4.5.3.2 U.A.E Oncology Drugs Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Oncology Drugs Market Overview
9.5.2 South and Central America Oncology Drugs Market Forecasts and Analysis
9.5.3 South and Central America Oncology Drugs Market Forecasts and Analysis - By Drug Class Type
9.5.4 South and Central America Oncology Drugs Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Oncology Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Oncology Drugs Market
9.5.5.1.1 Brazil Oncology Drugs Market by Drug Class Type
9.5.5.1.2 Brazil Oncology Drugs Market by Indication
9.5.5.2 Argentina Oncology Drugs Market
9.5.5.2.1 Argentina Oncology Drugs Market by Drug Class Type
9.5.5.2.2 Argentina Oncology Drugs Market by Indication

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ONCOLOGY DRUGS MARKET, KEY COMPANY PROFILES
11.1. ABBVIE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTELLAS PHARMA INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTRAZENECA PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BRISTOL-MYERS SQUIBB COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CELGENE CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JOHNSON AND JOHNSON (JANSSEN GLOBAL SERVICES, LLC,)
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MERCK AND CO., INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PFIZER INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Merck & Co., Inc.
3. JOHNSON & JOHNSON (Janssen Global Services, LLC)
4. Novartis AG
5. F. Hoffmann-La Roche Ltd
6. Bristol-Myers Squibb Company
7. AstraZeneca
8. AbbVie Inc.
9. Astellas Pharma Inc.
10. CELGENE CORPORATION
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book